Clinical Trial

Is 3D Modeling From Non-contrast CT Accurate for Minimally Invasive Lung Segmentectomies ?

Study acronym: 3D-LS
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
To assess the RELIABILITY in terms of accuracy of 3D-CT and 2D-CT reconstructions compared to intraoperative data regarding bronchovascular anatomy and tumor location. 3D CT reconstruction (CT scan without contrast injection) with Innersight3D® is equivalent to 2D CT (CT scan with contrast injection) for planning a minimally invasive lung segmentectomy. Evaluate the impact of 3D reconstruction (from a CT scan without injection of contrast agent) on intraoperative and postoperative results
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-14.
Trial Details
NCT Number NCT07234604
Lead Sponsor University Hospital, Strasbourg, France
Conditions Lung Cancer, Non-Small Cell Lung Cancer
Enrollment 50 participants
Start Date 2025-12-01
Primary Completion 2026-12-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-11-24